94 related articles for article (PubMed ID: 1257616)
1. Models for clinical disease. I. Biochemical cardiotoxicity of a coenzyme Q10-inhibitor in rats.
Combs AB; Kishi T; Porter TH; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):333-9. PubMed ID: 1257616
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant activity of a naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q10- enzyme systems.
Combs AB; Porter TH; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):109-14. PubMed ID: 1257593
[TBL] [Abstract][Full Text] [Related]
3. Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardium.
Bertazzoli C; Sala L; Ballerini L; Watanabe T; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):797-800. PubMed ID: 1005920
[TBL] [Abstract][Full Text] [Related]
4. Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension.
Yamagami T; Shibata N; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):721-7. PubMed ID: 785564
[TBL] [Abstract][Full Text] [Related]
5. Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs.
Kishi H; Kishi T; Folkers K
Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):533-40. PubMed ID: 1197930
[TBL] [Abstract][Full Text] [Related]
6. Antimetabolites of coenzyme Q. XV. Inhibition of mitochondrial reductase systems by naphthoquinone and quinolinequinone analogs.
Skelton FS; Porter TH; Littarru GP; Folkers K
Int J Vitam Nutr Res; 1973; 43(2):150-64. PubMed ID: 4351973
[No Abstract] [Full Text] [Related]
7. Potential bioreductive alkylating agents. 4. Inhibition of coenzyme Q enzyme systems by lipoidal benzoquinone and naphthoquinone derivatives.
Lin AJ; Pardini RS; Lillis BJ; Sartorelli AC
J Med Chem; 1974 Jul; 17(7):688-7. PubMed ID: 4151966
[No Abstract] [Full Text] [Related]
8. Bioenergetics in clinical medicine. IX. Gingival and leucocytic deficiencies of coenzyme Q10 in patients with periodontal disease.
Hansen IL; Iwamoto Y; Kishi T; Folkers K; Thompson LE
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):729-38. PubMed ID: 959667
[TBL] [Abstract][Full Text] [Related]
9. Study of the combined and separate administration of doxorubicin and coenzyme Q10 on mouse cardiac enzymes.
Choe JY; Combs AB; Saji S; Folkers K
Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):595-8. PubMed ID: 451343
[TBL] [Abstract][Full Text] [Related]
10. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
Conklin KA
Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
[TBL] [Abstract][Full Text] [Related]
11. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension.
Yamagami T; Shibata N; Folkers K
Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):273-88. PubMed ID: 1153873
[TBL] [Abstract][Full Text] [Related]
12. Prevention by coenzyme Q10 of the electrocardiographic changes induced by adriamycin in rats.
Choe JY; Combs AB; Folkers K
Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):199-202. PubMed ID: 441512
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a deficiency of coenzyme Q10 in human heart disease.
Folkers K; Littarru GP; Ho L; Runge TM; Havanonda S; Cooley D
Int Z Vitaminforsch; 1970; 40(3):380-90. PubMed ID: 5450999
[No Abstract] [Full Text] [Related]
14. Inhibition of two human tumor cell lines by antimetabolites of coenzyme Q10.
Folkers K; Porter TH; Bertino JR; Moroson B
Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):485-90. PubMed ID: 653103
[TBL] [Abstract][Full Text] [Related]
15. A new enzymic assay for human deficiencies of coenzyme Q10.
Nakamura R; Littarru GP; Folkers K
Int J Vitam Nutr Res; 1973 Apr; 43(4):526-36. PubMed ID: 4149067
[No Abstract] [Full Text] [Related]
16. Deficiency of activity of succinate dehydrogenase-coenzyme Q10 reductase in leucoytes from patiens with essential hypertension.
Yamagami T; Iwamoto Y; Folkers K
Int J Vitam Nutr Res; 1974; 44(3):404-14. PubMed ID: 4156526
[No Abstract] [Full Text] [Related]
17. HMG-CoA reductase inhibitors and coenzyme Q10.
Nawarskas JJ
Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
[TBL] [Abstract][Full Text] [Related]
18. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users.
Schaars CF; Stalenhoef AF
Curr Opin Lipidol; 2008 Dec; 19(6):553-7. PubMed ID: 18957876
[TBL] [Abstract][Full Text] [Related]
19. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.
Somayajulu M; McCarthy S; Hung M; Sikorska M; Borowy-Borowski H; Pandey S
Neurobiol Dis; 2005 Apr; 18(3):618-27. PubMed ID: 15755687
[TBL] [Abstract][Full Text] [Related]
20. Preservation of mitochondrial respiratory function by coenzyme Q10 in aged rat skeletal muscle.
Sugiyama S; Yamada K; Ozawa T
Biochem Mol Biol Int; 1995 Dec; 37(6):1111-20. PubMed ID: 8747541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
